A Comparative Study of Various FLT3-ITD Mutations

被引：0
|
作者：
Nordigarden, A. [1 ]
Halvarsson, C. [1 ]
Tang, Y. J. T. [1 ]
Jonsson, J. I. [1 ]
机构：
[1] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71171-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
506
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [21] PROGNOSTIC SIGNIFICANCE OF FLT3-ITD, FLT3-D835 MUTATIONS AND NPM1 MUTATIONS IN ACUTE MYELOGENOUS LEUKEMIA
    Zamora, L.
    Cabezon, M.
    Ribera, J.
    Marce, S.
    Morgades, M.
    Dominguez, D.
    Grau, J.
    Patino, B.
    Guardia, R.
    Granada, I.
    Ruiz-Xiville, N.
    Lloveras, N.
    Rodriguez, I.
    Junca, J.
    Oriol, A.
    Duarte, R.
    Fernandez de Sevilla, A.
    Ribera, J. M.
    Milla, F.
    Feliu, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 483 - 484
  • [22] Current Approaches to Transplantation for FLT3-ITD AML
    Bradley D. Hunter
    Yi-Bin Chen
    Current Hematologic Malignancy Reports, 2020, 15 : 1 - 8
  • [23] Current Approaches to Transplantation for FLT3-ITD AML
    Hunter, Bradley D.
    Chen, Yi-Bin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (01) : 1 - 8
  • [24] Not only TKI! Targeting FLT3-ITD by autophagy
    Marcucci, Guido
    Li, Ling
    BLOOD, 2016, 127 (07) : 796 - 797
  • [25] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
    Mona Salah
    Hamdy Zawam
    Neven Bahaa Fouad
    Nohair Soliman
    Fatma Abdel Wahab Abdel Maksoud
    Egyptian Journal of Medical Human Genetics, 22
  • [26] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
    Salah, Mona
    Zawam, Hamdy
    Fouad, Neven Bahaa
    Soliman, Nohair
    Maksoud, Fatma Abdel Wahab Abdel
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2021, 22 (01)
  • [27] Treatment of FLT3-ITD acute myeloid leukemia
    Fathi, Amir T.
    Chen, Yi-Bin
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2011, 1 (02): : 175 - 189
  • [28] FLT3-ITD activation mediates resistance to the BCL-2 selective antagonist, venetoclax, in FLT3-ITD mutant AML models
    Mali, Raghuveer
    Lasater, Elisabeth A.
    Doyle, Kelly
    Malla, Ritu
    Boghaert, Erwin
    Souers, Andrew
    Leverson, Joel
    Sampath, Deepak
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [29] Dual Inhibition of AKT/FLT3-ITD by A674563 Overcomes FLT3 Ligand-Induced Drug Resistance in FLT3-ITD positive AML
    Wang, Aoli
    Wu, Hong
    Chen, Cheng
    Hu, Chen
    Qi, Ziping
    Wang, Wenchao
    Yu, Kailin
    Liu, Xiaochuan
    Zou, Fengming
    Zhao, Zheng
    Wu, Jiaxin
    Liu, Juan
    Liu, Feiyang
    Wang, Li
    Stone, Richard M.
    Galinksy, Ilene A.
    Griffin, James D.
    Zhang, Shanchun
    Weisberg, Ellen L.
    Liu, Jing
    Liu, Qingsong
    ONCOTARGET, 2016, 7 (20) : 29131 - 29142
  • [30] Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
    Choi, Sujin
    Kim, Bo Kyung
    Ahn, Hong Yul
    Hong, Kyung Taek
    Choi, Jung Yoon
    Shin, Hee Young
    Kang, Hyoung Jin
    BLOOD RESEARCH, 2020, 55 (04) : 217 - 224
12345